Eden Research (LON:EDEN) Releases Earnings Results

Eden Research (LON:EDEN) announced its earnings results on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative return on equity of 15.05% and a negative net margin of 44.31%.

Eden Research Stock Performance

LON EDEN traded up GBX 0.05 during trading on Wednesday, reaching GBX 2.40. 832,329 shares of the company’s stock were exchanged, compared to its average volume of 585,744. The company has a debt-to-equity ratio of 1.43, a current ratio of 2.25 and a quick ratio of 2.42. The stock has a market capitalization of £19.28 million, a P/E ratio of -5.42 and a beta of 1.57. Eden Research has a fifty-two week low of GBX 1.96 and a fifty-two week high of GBX 5. The business has a 50 day moving average price of GBX 2.73 and a 200-day moving average price of GBX 3.17.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.